Halozyme Therapeutics Inc (HALO)
49.00
+3.30
(+7.22%)
USD |
NASDAQ |
Nov 22, 16:00
48.52
-0.48
(-0.98%)
After-Hours: 20:00
Halozyme Therapeutics Price: 49.00 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 48.93 | 49.57 | 46.21 | 49.00 | 4.544M |
| Nov 21, 2024 | 45.85 | 46.12 | 44.80 | 45.70 | 1.298M |
| Nov 20, 2024 | 44.57 | 46.20 | 44.10 | 45.76 | 1.876M |
| Nov 19, 2024 | 43.81 | 45.30 | 42.65 | 44.81 | 3.772M |
| Nov 18, 2024 | 45.66 | 45.71 | 42.01 | 42.57 | 5.485M |
| Nov 15, 2024 | 48.81 | 49.64 | 45.62 | 45.65 | 7.231M |
| Nov 14, 2024 | 58.25 | 59.80 | 53.84 | 53.96 | 3.219M |
| Nov 13, 2024 | 59.79 | 60.37 | 58.46 | 58.61 | 830665.0 |
| Nov 12, 2024 | 61.08 | 62.02 | 59.24 | 59.61 | 1.511M |
| Nov 11, 2024 | 61.13 | 62.13 | 60.55 | 61.09 | 1.470M |
| Nov 08, 2024 | 59.65 | 61.19 | 59.14 | 60.98 | 1.116M |
| Nov 07, 2024 | 60.66 | 60.95 | 58.76 | 59.65 | 1.064M |
| Nov 06, 2024 | 60.55 | 61.49 | 58.00 | 60.63 | 1.530M |
| Nov 05, 2024 | 58.00 | 58.74 | 57.08 | 58.72 | 1.140M |
| Nov 04, 2024 | 56.82 | 59.39 | 56.82 | 58.47 | 2.122M |
| Nov 01, 2024 | 55.66 | 57.62 | 52.56 | 57.15 | 3.404M |
| Oct 31, 2024 | 50.56 | 51.21 | 50.01 | 50.57 | 1.912M |
| Oct 30, 2024 | 50.46 | 51.08 | 50.03 | 50.59 | 741188.0 |
| Oct 29, 2024 | 50.17 | 50.96 | 50.10 | 50.64 | 538246.0 |
| Oct 28, 2024 | 49.72 | 50.78 | 49.71 | 50.46 | 1.168M |
| Oct 25, 2024 | 49.35 | 49.84 | 48.84 | 49.25 | 789585.0 |
| Oct 24, 2024 | 50.79 | 50.79 | 49.12 | 49.30 | 1.039M |
| Oct 23, 2024 | 51.46 | 51.70 | 50.51 | 50.80 | 991796.0 |
| Oct 22, 2024 | 51.68 | 52.02 | 51.14 | 51.55 | 1.111M |
| Oct 21, 2024 | 52.60 | 52.77 | 51.45 | 51.77 | 1.101M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.90
Minimum
Mar 18 2020
64.42
Maximum
Aug 28 2024
39.36
Average
40.26
Median
Price Benchmarks
| Lexicon Pharmaceuticals Inc | 0.8634 |
| Novavax Inc | 8.47 |
| Kura Oncology Inc | 10.80 |
| TransMedics Group Inc | 76.04 |
| Pulmonx Corp | 6.79 |
Price Related Metrics
| PE Ratio | 16.23 |
| PS Ratio | 6.715 |
| PEG Ratio | 0.2676 |
| Price to Book Value | 13.77 |
| Price to Free Cash Flow | 16.20 |
| Earnings Yield | 6.16% |
| Market Cap | 6.234B |
| PEGY Ratio | 0.2676 |
| Operating PE Ratio | 13.34 |
| Normalized PE Ratio | 17.00 |